date,title,source
Oct-18-18,Natera and Neon Therapeutics Announce Clinical Trial Collaboration to Assess Treatment Response to Personal Cancer Vaccine,GlobeNewswire
Oct-19-18,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",Benzinga
Oct-22-18,Neon Therapeutics Presents Data from Ongoing Phase 1b NT-001 Clinical Trial at European Society for Medical Oncology 2018 Congress,GlobeNewswire
Nov-07-18,Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors,GlobeNewswire
Nov-12-18,Neon Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights,GlobeNewswire
Nov-16-18,Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe,GlobeNewswire
Dec-06-18,Neon Therapeutics and Apexigen Announce First Patient Dosed in Neons NT-003 Phase 1b Combination Trial of NEO-PV-01 in Metastatic Melanoma,GlobeNewswire
Jan-03-19,Neon Therapeutics Provides Business Update and Outlook for 2019,GlobeNewswire
Jan-04-19,"Can We See Significant Institutional Ownership On The Neon Therapeutics, Inc. (NASDAQ:NTGN) Share Register?",Simply Wall St.
Feb-06-19,These 4 Biotech Stocks Are Leading The Industry,ACCESSWIRE
Feb-21-19,Neon Therapeutics to Present at 8th Annual Leerink Partners Global Healthcare Conference,GlobeNewswire
Mar-04-19,Neon Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference,GlobeNewswire
Mar-11-19,Neon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update,GlobeNewswire
Apr-08-19,Neon Therapeutics Announces Completion of Enrollment in Phase 1b NT-002 Clinical Trial of NEO-PV-01 in Metastatic Non-Small Cell Lung Cancer,GlobeNewswire
